These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14672715)

  • 21. Phenotypic variability associated with Arg26Gln mutation in caveolin3.
    Fee DB; So YT; Barraza C; Figueroa KP; Pulst SM
    Muscle Nerve; 2004 Sep; 30(3):375-8. PubMed ID: 15318349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E).
    Bönnemann CG; Passos-Bueno MR; McNally EM; Vainzof M; de Sá Moreira E; Marie SK; Pavanello RC; Noguchi S; Ozawa E; Zatz M; Kunkel LM
    Hum Mol Genet; 1996 Dec; 5(12):1953-61. PubMed ID: 8968749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
    Volonte D; Peoples AJ; Galbiati F
    Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).
    Muchir A; Bonne G; van der Kooi AJ; van Meegen M; Baas F; Bolhuis PA; de Visser M; Schwartz K
    Hum Mol Genet; 2000 May; 9(9):1453-9. PubMed ID: 10814726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy.
    Tateyama M; Aoki M; Nishino I; Hayashi YK; Sekiguchi S; Shiga Y; Takahashi T; Onodera Y; Haginoya K; Kobayashi K; Iinuma K; Nonaka I; Arahata K; Itoyama Y
    Neurology; 2002 Jan; 58(2):323-5. PubMed ID: 11805270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.
    Betz RC; Schoser BG; Kasper D; Ricker K; Ramírez A; Stein V; Torbergsen T; Lee YA; Nöthen MM; Wienker TF; Malin JP; Propping P; Reis A; Mortier W; Jentsch TJ; Vorgerd M; Kubisch C
    Nat Genet; 2001 Jul; 28(3):218-9. PubMed ID: 11431690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
    Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
    BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia.
    Alias L; Gallano P; Moreno D; Pujol R; Martínez-Matos JA; Baiget M; Ferrer I; Olivé M
    Neuromuscul Disord; 2004 May; 14(5):321-4. PubMed ID: 15099591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.
    Meyer T; Pankuweit S; Richter A; Maisch B; Ruppert V
    Gene; 2013 Sep; 527(1):416-20. PubMed ID: 23816408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
    Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
    Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caveolin-3 deficiency causes muscle degeneration in mice.
    Hagiwara Y; Sasaoka T; Araishi K; Imamura M; Yorifuji H; Nonaka I; Ozawa E; Kikuchi T
    Hum Mol Genet; 2000 Dec; 9(20):3047-54. PubMed ID: 11115849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Hitomi N; Kubo T; Kitaoka H; Hirota T; Hamada T; Hoshikawa E; Hayato K; Okawa M; Kimura A; Doi YL
    J Cardiol; 2010 Sep; 56(2):189-96. PubMed ID: 20605413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A frame shift mutation, Arg346fs mutation, is identified in cardiac myosin-binding protein C gene in a Chinese family with hypertrophic cardiomyopathy].
    Xie WL; Liu WL; Hu DY; Cui W; Zhu TG; Li CL; Sun YH; Li L; Bian H
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):963-6. PubMed ID: 16061003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy.
    Valdés-Mas R; Gutiérrez-Fernández A; Gómez J; Coto E; Astudillo A; Puente DA; Reguero JR; Álvarez V; Morís C; León D; Martín M; Puente XS; López-Otín C
    Nat Commun; 2014 Oct; 5():5326. PubMed ID: 25351925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel hypertrophic cardiomyopathy-associated mutation using targeted next-generation sequencing.
    Zhao Y; Feng Y; Ding X; Dong S; Zhang H; Ding J; Xia X
    Int J Mol Med; 2017 Jul; 40(1):121-129. PubMed ID: 28498465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity.
    Stefanelli CB; Rosenthal A; Borisov AB; Ensing GJ; Russell MW
    Mol Genet Metab; 2004; 83(1-2):188-96. PubMed ID: 15464434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new mutational mechanism for hypertrophic cardiomyopathy.
    Pezzoli L; Sana ME; Ferrazzi P; Iascone M
    Gene; 2012 Oct; 507(2):165-9. PubMed ID: 22820391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
    Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
    J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.